The KM plotter analysis revealed that MAMDC2 expression level is closely associated with the survival rates of the breast cancer patients in the ER+ group (Figure 1H), which was completely abrogated in the triple‐negative subtype (Figure 1I). This evidence concerns the gene MAMDC2 and breast carcinoma.